Skip to Content


Dosage form: liquid
Ingredients: Chlorcyclizine Hydrochloride 25mg in 5mL, Codeine Phosphate 10mg in 5mL, Phenylephrine Hydrochloride 10mg in 5mL
Labeler: Hawthorn Pharmaceuticals, Inc.
NDC Code: 63717-276

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Nasotuss Liquid

Active ingredients (in each 5 mL teaspoonful)
Chlorcyclizine Hydrochloride 25 mg
Codeine Phosphate 10 mg
Phenylephrine Hydrochloride 10 mg

PurposeAntihistamine, Antitussive, Decongestant

Usestemporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, water eyes
  • cough due to minor throat and bronchial irritation
  • nasal congestion
  • reduces swelling of the nasal passages

WarningsDo not exceed recommended dosage.

Do not use this product
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have
  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • difficulty in urination due to the enlargement of the prostate gland
  • a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
  • a cough that occurs with too much phlegm
  • a chronic pulmonary disease or shortness of breath, or children who are taking other drugs
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes

Ask a doctor or pharmacist before use if you aretaking sedatives or tranquilizers.

When using this product
  • excitability may occur, especially in children
  • may cause marked drowsiness
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if
  • nervousness, dizziness, or sleeplessness occur
  • may cause or aggravate constipation
  • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache.  These could be signs of a serious condition.
  • new symptoms occur

If pregnant or breast-feeding,ask a health professional before use.

Keep out of the reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.

Directions Do not exceed recommended dosage.
Adults and children
12 years of age
and older:

1 teaspoonful (5 mL) every
6 to 8 hours, not to exceed
3 teaspoonfuls in a
24 hour period.
Children 6 to under
12 years of age:

1/2 teaspoonful
(2.5 mL) every
6 - 8 hours, not to exceed 1 1/2
teaspoonfuls in a
24 hour period.
Children under 6
years of age:
Consult a doctor

Other informationStore at 20° to 25° C (68° to 77°F).

Inactive ingredientsCitric Acid, Sodium Citrate Dihydrate, Sucralose, Propylene Glycol, Sorbitol, Glycerin, Raspberry Flavor, and Deionized Water.

Questions? Comments?Call 1-888-455-5253 Monday - Friday, 8:00 a.m.- 5:00 p.m. (CT)
Serious side effects associated with use of this product may be reported to this number.

Tamper evident by foil seal under cap.  Do not use if foil seal is broken or missing.

Patent Pending

Manufactured for:
Hawthorn Pharmaceuticals, Inc.
Madison, MS  39110

HI262  08/10

Product PackagingThe packing below represents the labeling currently used:

Principal Display Panel and Side Panel for 473 mL label:

NDC 63717-276-16

Patent Pending

nasotuss Liquid

Antihistamine / Antitussive / Decongestant

Each teaspoonful (5mL) for oral administration contains:

Chlorcyclizine HCl................................25 mg
Codeine Phosphate..............................10 mg
Phenylephrine HCl................................10 mg

Rx Only

For Professional Use

Dye Free / Sugar Free / Alcohol Free

Raspberry Flavor


16 fl oz (473 mL)

USUAL DOSAGE:  See Drug Facts for Complete Dosage Recommendations.

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]

Tamper evident by foil seal under cap.  Do not use if foil seal is broken or missing.

This bottle is not to be dispensed to the consumer.

Dispense in a tight, light-resistant container with a child-resistant closure.

Call you doctor for medical advise about side effects.  You may report side effects
to FDA at 1-800-FDA-1088 (Toll Free).

Manufactured for:
Hawthorn Pharmaceuticals, Inc., Madison, MS  39910

HL219  08/10

chlorcyclizine hydrochloride, codeine phosphate, phenylephrine hydrochloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63717-276
Route of AdministrationORALDEA ScheduleCV    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Chlorcyclizine Hydrochloride (Chlorcyclizine) Chlorcyclizine Hydrochloride25 mg  in 5 mL
Codeine Phosphate (Codeine) Codeine Phosphate10 mg  in 5 mL
Phenylephrine Hydrochloride (Phenylephrine) Phenylephrine Hydrochloride10 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
Citric Acid 
Trisodium Citrate Dihydrate 
Propylene Glycol 
Product Characteristics
Color    Score    
FlavorRASPBERRYImprint Code
#Item CodePackage Description
1NDC:63717-276-16473 mL in 1 BOTTLE
2NDC:63717-276-9912 BOTTLE (BOTTLE) in 1 CARTON
215 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34111/08/2010
Labeler - Hawthorn Pharmaceuticals, Inc. (118049704)

Revised: 12/2010
Hawthorn Pharmaceuticals, Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.